Paradoxical decrease in high-density lipoprotein-cholesterol associated with statin-fenofibrate combination therapy

We read with interest the article by Van-Heyningen et al. presenting seven cases with a paradoxical fall in high-density lipoprotein-cholesterol (HDLC) associated with fenofibratestatin combination therapy. We too recognised this phenomenon and undertook a retrospective analysis of 100 consecutive d... View More